Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

NXF-00

Millipore

Natrix® Q Micro

Synonym(s):

Natrix® Q Membrane Adsorber

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

UNSPSC Code:
41115711

material

media (Macroporous Polymer)
polypropylene device

description

Natrix® Q Micro

product line

Natrix®

packaging

pack of 10 × 0.2 mL (devices)

parameter

1-5 mL/min flow rate
75 psi max. pressure

pore size

0.4 μm pore size

fitting

female inlet and outlet (luer)

application(s)

pharmaceutical

separation technique

strong anion exchange

storage temp.

2-30°C

Looking for similar products? Visit Product Comparison Guide

General description

Device Configuration: Flat-Sheet Capsule
The Natrix® Q Micro (0.2ml) is a scaled down, laboratory model for screening purposes, to fine tune buffer conditions, and assess load parameters before moving to small scale or commercial manufacturing.

Application

Chromatography

Biochem/physiol Actions

Purification of biomolecules via anion exchange chromatography

Features and Benefits

The revolutionary marcroporous polymer of Natrix® Q chromatography membrane contains a high density of quaternary amine binding sites enabling rapid mass transfer, delivering high binding capacity even at fast flow rates. The combination of performance and speed in a single-use, plug-and-play device format enables low risk, scalable solutions for efficient biomolecule purification.

Packaging

Carton, 10/pack

Legal Information

NATRIX is a registered trademark of Merck KGaA, Darmstadt, Germany

related product

Product No.
Description
Pricing

NXF-50

Natrix® Q Process 600

NXF-10

Natrix® Q Pilot

NXF-20

Natrix® Q Process 150

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Chromatographic Purification of Plasmid DNA (pDNA) for mRNA, Plasmid-based DNA Vaccines, and Viral Vector Applications

See case study examples of how to optimize chromatographic purification of plasmid DNA for Biopharmaceutical Applications.

Egg-based and Cell-based Influenza Vaccine Manufacturing Methods

Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.

Cost Modeling Vaccine Manufacturing: Estimate Production Costs for mRNA and other Vaccine Modalities

A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.

Developing and Manufacturing Attenuated Viral Vaccines

Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.

See All

Related Content

Adenovirus Vaccine Manufacturing Process

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.

Polishing Chromatography

Learn more on mAb downstream processing, more specifically polishing chromatography and the relevant associated products.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service